The Center for Veterinary Biologics regulates veterinary biologics (vaccines, bacterins, antisera, diagnostic kits, and other products of biological origin) to ensure that the veterinary biologics available for the diagnosis, prevention, and treatment of animal diseases are pure, safe, potent, and effective.

• USDA's BSE Testing - view most recent information
• Bovine Spongiform Encephalopathy (BSE) - view the current BSE Situation and Trade Initiatives
  

The Center:

• implements the provisions of the Virus-Serum-Toxin Act
• uses scientific information and regulatory processes to assure its customers that the veterinary biological products available for use are of high quality
• encourages open communication with stakeholders as new products and standards are developed
• promotes the use of quality assurance processes that inherently result in the production of pure, safe, potent, and effective veterinary biologics and diagnostics
• provides strong leadership in the development and international harmonization of standards for veterinary biological products
• maintains pharmacovigilance by encouraging the reporting of adverse events (unfavorable or unintended outcomes) occurring after the use of a veterinary biological products.

The Center personnel are committed to teamwork, continual learning, objectivity, balance, service, and fairness.